- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
SMS Pharmaceuticals Limited — Updates, 26-11-2025: Press Release
26-11-2025 | 08:22 am
26-11-2025 | 08:22 am
SMS Pharma's associate, VKT Pharma, secured US FDA approval for its reformulated Ranitidine (150mg & 300mg). This crucial development marks the medication's re-entry into the US market after a five-year absence, boosting market access.
No comments yet. Be the first to comment!